Business Description
Adocia is a French biotechnology company founded in 2005 and based in Lyon, focused on developing better treatments for diabetes and obesity. The company uses its proprietary delivery technology to improve how therapeutic proteins, particularly insulins, work in the body, with several products in clinical and early-stage development. Adocia has partnered with Tonghua Dongbao Pharmaceutical to bring one of its key insulin products to markets across China, Asia, and the Middle East.
